In vitro and in vivo effects of thymulin on rat testicular steroid synthesis.
Level 5 - mechanism / opinion, no new human data
Preclinical animal and in vitro tissue experiment
PubMed 9719447 · doi:10.1016/s0960-0760(98)00045-4
What was done
Testes from 3-, 6-, and 9-week-old rats were incubated in vitro with thymulin (0.1, 1, 10, and 100 ng/ml) with or without human chorionic gonadotropin (hCG, 1 IU/ml) to measure testosterone and estrone synthesis. In vivo effects were tested in 5-week-old pituitary-intact, hypophysectomized, and hCG-primed hypophysectomized rats given intravenous thymulin (1 or 10 microg), with steroid levels evaluated 30, 60, and 120 minutes post-injection.
What was found
In vitro, thymulin reduced testosterone and estrone synthesis in 3-week-old rat testes. In 6- and 9-week-old testes, low doses (0.1 and 1 ng/ml) stimulated testosterone and estrone synthesis, whereas high doses (100 ng/ml) decreased synthesis. Thymulin did not augment hCG stimulation in vitro. In vivo, thymulin had no effect in hypophysectomized rats, reduced testosterone and estrone in pituitary-intact rats, and significantly increased testosterone while decreasing estrone in hCG-primed hypophysectomized rats. The abstract reports no numeric values, variances, or p-values.
Why it matters
The findings characterize a direct thymus-testis regulatory link, showing that thymulin stimulatory action on male steroidogenesis depends on age, concentration, and prior gonadotropin exposure.
Limits
The study was conducted exclusively in rodents and isolated tissues, precluding direct clinical translation. Sample sizes and quantitative statistical data such as confidence intervals and exact steroid concentrations are omitted from the abstract. Mechanisms mediating the biphasic dose response were not fully defined.
Cited by
- supports In hypophysectomized animal models, administering thymulin alongside hCG produces greater testosterone output than hCG alone.